Skip to main content

Table 1 Patients demographics

From: The efficacy of alpha-1A blocker (tamsulosin), antimuscarinic (solifenacin) and their combination in the management of double-J stent-related lower urinary tract symptoms: a randomized controlled study

   Control Tamsulosin Solifenacin Combined therapy P value
Age Mean ± SD 38 ± 7 39 ± 1 40 ± 4 39 ± 8 0.55
Sex: n (%) Male 21 (53.8) 20 (58.8) 19 (51.4) 18 (54.4) 0.37
Female 18 (46.2) 14 (41.2) 18 (48.6) 15 (45.6)  
Side: n (%) Right 19 (48.7) 16 (47.1) 21 (56.8) 20 (60.6) 0.09
Left 20 (51.3) 18 (52.9) 16 (43.2) 13 (39.4)
Indications for stent fixation: n (%) URS 27 (69.2) 22 (64.7) 21(56.8) 23 (69.7) 0.64
ESWL 8 (20.5) 9 (26.5) 11(29.7) 7 (21.2)
PNL 4 (10.3) 3 (8.8) 5 (13.5) 3 (9.1)
Stone size (mm) In URS cases Mean ± SD 7.7 (1.9) 7.4 (1.9) 8.1 (2.2) 7.8 (1.8) 0.12
  1. URS Ureteroscopy, ESWL extracorporeal shock wave lithotripsy, PNL percutaneous nephrolithotomy